2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Blood Loss, Surgical | D016063 | 6 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Shah MH and Paradkar A | Effect of HLB of additives on the properties and drug release from the glyceryl monooleate matrices. | 2007 | Eur J Pharm Biopharm | pmid:17353118 |
| Nielsen LH et al. | Microcontainers as an oral delivery system for spray dried cubosomes containing ovalbumin. | 2017 | Eur J Pharm Biopharm | pmid:27993733 |
| Lopes LB et al. | Topical delivery of cyclosporin A: an in vitro study using monoolein as a penetration enhancer. | 2005 | Eur J Pharm Biopharm | pmid:15848052 |
| Ahmed AR et al. | Reduction in burst release of PLGA microparticles by incorporation into cubic phase-forming systems. | 2008 | Eur J Pharm Biopharm | pmid:18692569 |
| Esposito E et al. | Effect of nanostructured lipid vehicles on percutaneous absorption of curcumin. | 2014 | Eur J Pharm Biopharm | pmid:24361485 |
| Simonetti LD et al. | Assessment of the percutaneous penetration of cisplatin: the effect of monoolein and the drug skin penetration pathway. | 2009 | Eur J Pharm Biopharm | pmid:19442727 |
| Rossetti FC et al. | Optimization of protoporphyrin IX skin delivery for topical photodynamic therapy: Nanodispersions of liquid-crystalline phase as nanocarriers. | 2016 | Eur J Pharm Sci | pmid:26657201 |
| Nielsen LS et al. | Bioadhesive drug delivery systems. I. Characterisation of mucoadhesive properties of systems based on glyceryl mono-oleate and glyceryl monolinoleate. | 1998 | Eur J Pharm Sci | pmid:9795071 |
| Borgheti-Cardoso LN et al. | An in situ gelling liquid crystalline system based on monoglycerides and polyethylenimine for local delivery of siRNAs. | 2015 | Eur J Pharm Sci | pmid:25917525 |
| Patil SS et al. | Liquid crystalline phase as a probe for crystal engineering of lactose: carrier for pulmonary drug delivery. | 2015 | Eur J Pharm Sci | pmid:25460546 |